My father suffers from diabetic peripheral neuropathy. His diabetes led to nerve damage that causes him severe, constant pain. I want the best medical treatments possible for him and, as a neurologist, I am always on the lookout for good, new drugs, but none of them have effectively slowed down his diabetes and nerve damage. As long as experimenters continue to try to recreate diabetes in animals, instead of studying human diabetes, I have little hope that my father’s pain will end.
Although numerous drugs are available, diabetes remains among the top killers in the U.S. and worldwide. The newest drugs are generally no more effective than the older drugs or are much more harmful. Just recently, two new diabetic drugs, Onglyza and aleglitazar, failed clinical trials after testing in animals.
At first glance, it might seem that if we can recreate diabetes in dogs or mice, we would better understand diabetes. But here’s the problem: we end up better understanding animal diabetes– in dogs and mice– but not necessarily human diabetes.